Navigation Links
CyberKnife Cancer Institute of Chicago Is the First to Offer CyberKnife Treatment in the City of Chicago
Date:8/30/2012

CHICAGO, Aug. 30, 2012 /PRNewswire/ -- CyberKnife Cancer Institute of Chicago, a program of Swedish Covenant Hospital, is the first and only center within the City of Chicago to offer the revolutionary CyberKnife stereotactic radiosurgery treatment. The 10,000 sq. ft. state-of-the-art facility is treating patients with cancers of the brain, spine, pancreas, prostate, kidney, liver and lung. The technology is also effective for certain nervous system conditions like trigeminal neuralgia and arteriovenous malformations. The center is supported throughout the Chicagoland area by 24 credentialed physicians as well as a partnership with Radiology Oncology, S.C., a division of Alpha Med Physicians Group.

(Logo:  http://photos.prnewswire.com/prnh/20120830/CG65933LOGO)

As a non-invasive alternative to surgery, CyberKnife Robotic Radiosurgery can effectively treat complex tumors located virtually anywhere in the body. These treatments offer a reduced the risk of complications, allow the treatment of recurrent tumors, and are comfortable procedures that can usually be completed in around an hour per treatment.

"We are thrilled to have CyberKnife technology in Chicago and conveniently on Chicago's Magnificent Mile. It grants us the opportunity to treat patients with the most revolutionary tumor technology available for a higher level of patient care and ultimately treatment success," says Dr. Adam Dickler, Medical Director of the CyberKnife Cancer Institute of Chicago.

To learn more about CyberKnife and locate a referring physician, visit www.ckcancerchicago.com.

About CyberKnife Cancer Institute of Chicago, a program of Swedish Covenant Hospital

CyberKnife Cancer Institute of Chicago is the only center within the city of Chicago to offer the revolutionary CyberKnife stereotactic radiosurgery system. The 10,000 sq. ft. state-of-the-art facility is supported by a diverse team of skilled radiation oncologists in partnership with Swedish Covenant Hospital. The CyberKnife Cancer Institute of Chicago is located in downtown Chicago, just steps from the Magnificent Mile and is easily accessible by public transportation and offers free underground parking for patients www.ckcancerchicago.com. CyberKnife® is a registered trademark of Accuray Incorporated and is used with permission.

Press contact: Leigh Ginther, lginther@schosp.org or 773-989-1685.


'/>"/>
SOURCE CyberKnife Cancer Institute of Chicago
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CyberKnife System and the da Vinci Surgical System in Concord Medical Centers Achieve Over RMB 10 Million in Medical Revenue Since Opening in February
2. CyberKnife® Prostate SBRT Outcomes and Quality of Life Data Presented at American Urological Association Meeting
3. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
4. Quest Diagnostics Launches Molecular Cervical Cancer Test Based on National Institutes of Healths TERC Gene Marker
5. Polymedco Aligns with MedPrimex to Fight Colorectal Cancer in Mexico
6. Janssen Biotech Announces Global License and Development Agreement for Investigational Anti-Cancer Agent Daratumumab
7. Esperance Pharmaceuticals Announces Completion of Run-in Enrollment of Phase 2 Study of EP-100 Plus Paclitaxel in Advanced Ovarian Cancer
8. Breast Cancer Diagnostic and Drug Technologies: Global Markets
9. Human Vaccines & Immunotherapeutics Special Focus Highlights a Paradigm Shift in Cancer Vaccine Development
10. Brain Cancer Research in Seattle Leads to New Treatment Options for Patients
11. Aethlon Medical Discusses Therapeutic Device Strategies to Address Cancer, Hepatitis-C and Sepsis with the Wall Street Transcript
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
Breaking Medicine News(10 mins):